The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Flagged first, then by citations
2 of the 145 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 601–700 of 1,000
Busser, W. M. H., Arntz, M. J., Jenniskens, S. F. M., Deinum, J., Hoogeveen, Y. L., de Lange, F., & Kool, L. J. S. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0969-z · Cited by 20
Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism
Steichen, O., Lorthioir, A., Zinzindohoué, F., Plouin, P., & Amar, L. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.10.003 · Cited by 20
Hypokalaemia: Common Things Occur Commonly — a Retrospective Survey
Reid, A., Jones, G., & Isles, C. (2012) · JRSM Short Reports · doi:10.1258/shorts.2012.011179 · Cited by 20
Seccia, T. M., D, D. M. M., Toni, R. D., Maniero, C., Vincenzi, M., Motta, R., Pessina, A. C., & Rossi, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2172 · Cited by 20
Hypertension Caused by Primary Hyperaldosteronism: Increased Heart Damage and Cardiovascular Risk
Abad-Cardiel, M., Álvarez-Álvarez, B., Luque-Fernandez, L., Fernández, C., Fernández‐Cruz, A., & Claros, N. M. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.07.017 · Cited by 20
Kobayashi, H. H., Haketa, A., Ueno, T., Suzuki, R., Aoi, N., Ikeda, Y., Tahira, K., Hatanaka, Y., Tanaka, S., Otsuka, H., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12998 · Cited by 20
van der Gugten, J. G., & Holmes, D. T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3182-8_26 · Cited by 20
Chakera, A. J., McDonald, T. J., Knight, B., Vaidya, B., & Jones, A. G. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-1-18 · Cited by 20
Beltsevich, D. G., Mel'nichenko, G. A., Kuznetsov, N. S., Troshina, E. A., Platonova, N. M., Vanushko, V. E., Yukina, M. Y., & Молашенко, Н. В. (2016) · Endocrine Surgery · doi:10.14341/serg2016431-42 · Cited by 21
Familial hyperaldosteronism type III a novel case and review of literature
Fernández, N. P., Moreno, F., Morata, J., Gutiérrez, A. M., León, S., Mingo, C. D., Zúñiga, Á., & Calvo, F. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9481-0 · Cited by 20
Harvey, A. M. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.007 · Cited by 21
Factors affecting parathyroid hormone levels in different types of primary aldosteronism
Jiang, Y., Zhang, C., Ye, L., Su, T., Zhou, W., Jiang, L., Zhang, Y., & Wang, W. (2015) · Clinical Endocrinology · doi:10.1111/cen.12981 · Cited by 20
Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study
Uchida, T., Nishimoto, K., Fukumura, Y., Asahina, M., Goto, H., Kawano, Y., Shimizu, F., Tsujimura, A., Seki, T., Mukai, K., et al. (2016) · Endocrine Pathology · doi:10.1007/s12022-016-9441-8 · Cited by 22
Role of adrenal vein sampling in primary aldosteronism: the M onash H ealth experience
Teng, J., Hutchinson, M. E., Doery, J. C. G., Choy, K. W., Chong, W., Fuller, P. J., & Yang, J. (2015) · Internal Medicine Journal · doi:10.1111/imj.12873 · Cited by 19
Evidence-Based Diuretic Therapy for Improving Cardiovascular Prognosis in Systemic Hypertension
Badarin, F. J. A., Abuannadi, M., Lavie, C. J., & O’Keefe, J. H. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.12.016 · Cited by 19
Rossi, G. P., Bagordo, D., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Jr., Naruse, M., Deinum, J., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21247 · Cited by 19
Genetics of Primary Aldosteronism
Funder, J. W. (2014) · Frontiers of hormone research · doi:10.1159/000360870 · Cited by 19
Self-citationThe Evaluation and Treatment of Endocrine Forms of Hypertension
Velasco, A., & Vongpatanasin, W. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0528-x · Cited by 19
Tanase‐Nakao, K., Naruse, M., Nanba, K., Tsuiki, M., Tagami, T., Usui, T., Okuno, H. G., Shimatsu, A., Hashimoto, S., Katabami, T., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12497 · Cited by 19
Kishimoto, R., Oki, K., Yoneda, M., Gómez-Sánchez, C. E., Ohno, H., Kobuke, K., Itcho, K., & Kohno, N. (2016) · Medicine · doi:10.1097/md.0000000000003659 · Cited by 19
Sertedaki, A., Markou, Α., Vlachakis, D., Κοσσίδα, Σ., Campanac, E., Hoffman, D. A., Sierra, M. D. L. L., Xekouki, P., Stratakis, C. A., Kaltsas, G., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13132 · Cited by 19
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism
Hannon, M., Sze, W.-C., Carpenter, R., Parvanta, L., Matson, M. B., Sahdev, A., Druce, M., Berney, D. M., Waterhouse, M., Akker, S., et al. (2016) · QJM · doi:10.1093/qjmed/hcw194 · Cited by 19
Nilubol, N., Soldin, S. J., Patel, D., Rwenji, M., Gu, J., Masika, L., Chang, R., Stratakis, C. A., & Kebebew, E. (2017) · International Journal of Endocrine Oncology · doi:10.2217/ije-2016-0020 · Cited by 19
Old and new genes in primary aldosteronism
Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101375 · Cited by 20
Torresan, F., Rossitto, G., Bisogni, V., Lerco, S., Maiolino, G., Cesari, M., Zhu, R., Iacobone, M., Seccia, T. M., & Rossi, G. P. (2020) · Clinical Science · doi:10.1042/cs20200340 · Cited by 21
Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience
Kocjan, T., Jensterle, M., Vidmar, G., Vrckovnik, R., Berden, P., & Stankovič, M. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0052 · Cited by 19
Two-site automated chemiluminescent assay for measurement of immunoreactive renin
Gruson, D., Maisin, D., Lison, P., Maiter, D. M., & Persu, A. (2011) · Biomarkers · doi:10.3109/1354750x.2011.614015 · Cited by 19
van der Gugten, J. G., & Holmes, D. T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3182-8_5 · Cited by 19
Zennaro, M., & Jeunemaı̂tre, X. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.02.006 · Cited by 19
Griffin, T. P., Wall, D., Browne, G. A., Dennedy, M. C., & O’Shea, P. M. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217728964 · Cited by 21
Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism
Balaş, M., Zosin, I., Maser‐Gluth, C., Hermsen, D. F., Cupisti, K., Schott, M., Schinner, S., Knoefel, W. T., Scherbaum, W. A., & Willenberg, H. S. (2010) · Hypertension Research · doi:10.1038/hr.2010.76 · Cited by 19
Primary Aldosteronism: Clinical Lateralization and Costs
Funder, J. W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3046 · Cited by 19
Self-citationRossitto, G., D, D. M. M., Battistel, M., Barbiero, G., Maiolino, G., Bisogni, V., Sanga, V., & Rossi, G. P. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001082 · Cited by 18
Rossi, C., Cicalini, I., Verrocchio, S., Dalmazi, G. D., Federici, L., & Bucci, I. (2020) · Biomedicines · doi:10.3390/biomedicines8090314 · Cited by 21
He, K., Zhang, Z., Wang, Z., Wang, Y., Wang, Y., Zhang, H., Dong, Y., & Xiao, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.634879 · Cited by 18
Rowe, N. E., Kumar, R., Schieda, N., Siddiqi, F. S., McGregor, T. B., McAlpine, K., Violette, P. D., Bathini, V., Eng, M. K., & Izard, J. (2023) · Canadian Urological Association Journal · doi:10.5489/cuaj.8248 · Cited by 18
Graham, U. M., Ellis, P. K., Hunter, S. J., Leslie, H., Mullan, K., & Atkinson, A. B. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04177.x · Cited by 18
Adrenocortical Causes of Hypertension
Moraitis, A. G., & Stratakis, C. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/624691 · Cited by 18
Shortened saline infusion test for subtype prediction in primary aldosteronism
Nanba, K., Tsuiki, M., Umakoshi, H., Nanba, A. T., Hirokawa, Y., Usui, T., Tagami, T., Shimatsu, A., Suzuki, T., Tanabe, A., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0615-9 · Cited by 18
Rehabilitation of patients with stroke: summary of SIGN guidance
Smith, L. N., James, R., Barber, M., Ramsay, S., Gillespie, D. C., Chung, C., & on behalf of the Guideline Development Group (2010) · BMJ · doi:10.1136/bmj.c2845 · Cited by 18
Primary aldosteronism and low-renin hypertension: a continuum?
Funder, J. W. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft052 · Cited by 18
Self-citationSodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population
Li, Y., Liu, Y., Li, J., Wang, X., & Yu, Y. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2840 · Cited by 18
Péchère-Bertschi, A., Herpin, D., & Lefèbvre, H. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.010 · Cited by 18
Normoaldosteronemic aldosterone-producing adenoma
Rossi, G. P., Gioco, F., Fassina, A., & Gómez-Sánchez, C. E. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000748 · Cited by 18
PREVALENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION
Galati, S.-J., Cheesman, K. C., Springer-Miller, R., Hopkins, S. M., Krakoff, L. R., Bagiella, E., Zhuk, R. A., Ying, T. K., Amer, C., Boyajian, M. K., et al. (2016) · Endocrine Practice · doi:10.4158/e161332.or · Cited by 19
Diagnosing endocrine hypertension: a practical approach
Yang, J., Shen, J., & Fuller, P. J. (2017) · Nephrology · doi:10.1111/nep.13078 · Cited by 19
Jia, W. P., Li, S., Liu, Q., Zhu, Y., Wu, N., Tang, Y., Li, Q., Ren, K., Zhang, Q., Yu, Y., et al. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0250-6 · Cited by 18
Goff, C. M. L., González‐Antuña, A., Peeters, S. D., Fabregat-Cabello, N., van der Gugten, J. G., Vroonen, L., Pottel, H., Holmes, D. T., & Cavalier, E. (2018) · Clinical mass spectrometry · doi:10.1016/j.clinms.2018.06.002 · Cited by 18
Tuersun, T., Luo, Q., Zhang, Z., Wang, G., Zhang, D., Wang, M., Wu, T., Zhou, K., Yue, N., & Li, N. (2020) · Hypertension Research · doi:10.1038/s41440-020-0529-7 · Cited by 18
Galati, S.-J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.010 · Cited by 18
Clinical Management of Primary Aldosteronism
Rossi, G. P., & Cà, A. D. (2014) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-014-0039-2 · Cited by 18
Regulation of aldosterone biosynthesis by the K ir3.4 ( KCNJ 5) potassium channel
Velarde‐Miranda, C., Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12151 · Cited by 18
Vink, E. E., de Boer, A., Hoogduin, H. M., Voskuil, M., Leiner, T., Bots, M. L., Joles, J. A., & Blankestijn, P. J. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000436 · Cited by 18
Barigou, M., Ah-Kang, F., Orloff, E., Amar, J., Chamontin, B., & Bouhanick, B. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.04.017 · Cited by 18
Changes in the clinical manifestations of primary aldosteronism
Kim, S. H., Ahn, J. H., Hong, H. C., Choi, H. Y., Kim, Y. J., Kim, N. H., Yoo, H. J., Kim, H. Y., Seo, J. A., Kim, N. H., et al. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.2.217 · Cited by 18
Luo, Q., Li, N., Wang, M., Yao, X., Heizhati, M., Zhang, D., Zhou, K., Wang, G., Hu, J., & Zhu, B. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0291-y · Cited by 17
Sousa, K. D., Abdellatif, A. B., Giscos-Douriez, I., Méatchi, T., Amar, L., Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab707 · Cited by 17
Caprio, M., Mammi, C., Jaffe, I. Z., Zennaro, M., Aversa, A., Mendelsohn, M. E., Fabbri, A., & Rosano, G. M. C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898743 · Cited by 17
A clinical prediction score for diagnosing unilateral primary Aldosteronism may not be generalizable
Venos, E., So, B., Dias, V. C., Harvey, A. M., Pasieka, J. L., & Kline, G. A. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-94 · Cited by 18
A differential diagnosis of inherited endocrine tumors and their tumor counterparts
Toledo, S. P. A., Lourenço, D. M., & Toledo, R. A. (2013) · Clinics · doi:10.6061/clinics/2013(07)24 · Cited by 16
Adrenal Radiofrequency Ablation in Swine: Change in Blood Pressure and Histopathologic Analysis
Yamakado, K., Takaki, H., Uchida, K., Nakatsuka, A., Shiraishi, T., & Takeda, K. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-010-0078-6 · Cited by 17
Lebel, M., Corbin, & Douville, P. (2011) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s22245 · Cited by 17
Amar, L., Lorthioir, A., Azizi, M., & Plouin, P. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0585 · Cited by 17
Diagnosis and Management of Primary Aldosteronism
Wu, V., Chao, C., Kuo, C., Lin, Y., Chueh, S., & Wu, K. (2012) · Acta Nephrologica · doi:10.6221/an.2012005 · Cited by 17
Salem, V., Hopkins, T. G., El-Gayar, H., Zac‐Varghese, S., Goldstone, A. P., Todd, J., Dhillo, W. S., Field, B. C. T., Martin, N. M., Hatfield, E. C. I., et al. (2012) · HORMONES · doi:10.14310/horm.2002.1342 · Cited by 17
Aldosterone and type 2 diabetes mellitus
Zavatta, G., Casadio, E., Rinaldi, E., Pagotto, U., Pasquali, R., & Vicennati, V. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0065 · Cited by 18
Primary Aldosteronism: Present and Future
Funder, J. W. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.006 · Cited by 17
Self-citationLupi, A., Battistel, M., Barbiero, G., D, D. M. M., Rossi, G. P., & Quaia, E. (2019) · European Radiology · doi:10.1007/s00330-019-06209-5 · Cited by 17
Kietsiriroje, N., Wonghirundecha, R., Suntornlohanakul, O., & Murray, R. D. (2019) · Clinical Endocrinology · doi:10.1111/cen.14142 · Cited by 17
Carey, R. M. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23206 · Cited by 17
Self-citationMa, D., Liu, X., Zeng, L., Yuan, P., Liu, Z., Xie, J., Yuan, G., Wang, S., Yu, X., Yang, Y., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002634 · Cited by 17
Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism
Naruse, M., Tanabe, A., Yamamoto, K. I., Rakugi, H., Kometani, M., Yoneda, T., Kobayashi, H. H., Abe, M., Ohno, Y., Inagaki, N., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1192 · Cited by 17
Chen, F., Cheng, Z., Wang, Z., Peng, Y., Wang, B., Guo, W., & Pan, B. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.123030 · Cited by 17
Chen, P., Chang, D., Liu, K., Liao, W., Wang, W., Chang, C., Wu, V., & Lin, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-12835-9 · Cited by 17
Kisaka, T., Ozono, R., Ishida, T., Higashi, Y., Oshima, T., & Kihara, Y. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328359862d · Cited by 17
Chang, Y., Lee, H., Hung, C., Wu, X.-M., Lee, J., Wang, S., Liao, M., Chen, Y.-H., Wu, V., Wu, K., et al. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.05.062 · Cited by 17
Mark, P. B., Boyle, S., Zimmerli, L., McQuarrie, E. P., Delles, C., & Freel, E. M. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.70 · Cited by 17
Kotliar, C., Inserra, F., Forcada, P. J., de Cavanagh, E. M. V., Obregon, S., Navari, C., Castellaro, C., & Sanchez, R. A. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833487d4 · Cited by 17
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma
Papanastasiou, L., Παππά, Θ., Samara, C., Apostolopoulou, G., Tsiavos, V., Markou, Α., Alexandraki, K., Piaditis, G. P., Chrousos, G. P., & Kaltsas, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02707.x · Cited by 17
Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells
Hardege, I., Xu, S., Gordon, R. D., Thompson, A. J., Figg, N. L., Stowasser, M., Murrell‐Lagnado, R. D., & O’Shaughnessy, K. M. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1195 · Cited by 17
Self-citationTurner, D. J., & Miskulin, J. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831d2aa9 · Cited by 17
Current views on the diagnosis and management of hypokalaemia in children
Zieg, J., Gonsorčíková, L., & Landau, D. (2016) · Acta Paediatrica · doi:10.1111/apa.13398 · Cited by 17
A useful tool to improve the case detection rate of primary aldosteronism
Rossi, G. P., & Bisogni, V. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000892 · Cited by 17
Primary aldosteronism in the primary care setting
Buffolo, F., Monticone, S., Tetti, M., & Mulatero, P. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000408 · Cited by 18
Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
Takasago, Y., Hirooka, K., Nakano, Y., Kobayashi, M., & Ono, A. (2018) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320318795001 · Cited by 17
Morimoto, R., Kudo, M., Murakami, O., Takase, K., Ishidoya, S., Nakamura, Y., Ishibashi, T., Takahashi, S. I., Arai, Y., Suzuki, T., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.35 · Cited by 17
Screening for primary aldosteronism in a primary care unit
Volpe, C., Wahrenberg, H., Hamberger, B., & Thorén, M. C. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312463833 · Cited by 17
Griffin, T. P., Browne, G. A., Wall, D., Dennedy, M. C., & O’Shea, P. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000775 · Cited by 17
Is Familial Hyperaldosteronism Underdiagnosed in Hypertensive Children?
Mulatero, P., Williams, T. A., Monticone, S., & Veglio, F. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.172916 · Cited by 17
Aldosterone and Metabolic Dysfunction
Pimenta, E., & Calhoun, D. A. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123406 · Cited by 17
Yin, Y., Ma, C., Yu, S., Ai, Q., Han, C., Zhong, J., Luo, W., Ma, X., Yu, J., Zhang, Y., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117325 · Cited by 16
Castro, M. A., Ruiz-Sánchez, J. G., Ramírez, P. A. P., Rojas‐Marcos, P. M., Aguilera-Saborido, A., Cerezo, J. F. G., Lazareno, N. L., Quesada, M. E. T., Ramos, J. G., Oriola, J., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03773-9 · Cited by 16
Mineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension
Ardhanari, S., Kannuswamy, R., Chaudhary, K. R., Lockette, W. E., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.03.002 · Cited by 16
Kunikata, H., Aizawa, N., Kudo, M., Mugikura, S., Nitta, F., Morimoto, R., Iwakura, Y., Ono, Y., Satoh, F., Takahashi, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117452 · Cited by 16
Sacks, B. A., Brook, O. R., & Brennan, I. M. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835f26c9 · Cited by 16
Monogenic Hypertension in Children: A Review With Emphasis on Genetics
Aggarwal, A., & Rodriguez‐Buritica, D. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.09.006 · Cited by 17
Primary aldosteronism: Treatment of the disease, and new therapeutic approaches
Funder, J. W. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101368 · Cited by 16
Self-citationSuntornlohanakul, O., Soonthornpun, S., Srisintorn, W., Murray, R. D., & Kietsiriroje, N. (2020) · Clinical Endocrinology · doi:10.1111/cen.14210 · Cited by 16
Diagnostic modalities of the most common forms of secondary hypertension.
Kallistratos, M. S., Giannakopoulos, A., German, V., & Manolis, A. J. (2010) · PubMed · Cited by 16
Federal clinical practice guidelines on the diagnostics and treatment of adrenocortical cancer
Mel'nichenko, G. A., Stilidi, I. S., Alekseev, B. Y., Gorbunova, V. A., Beltsevich, D. G., Райхман, А. О., Kuznetsov, N. S., Zhukov, N. V., & Bokhyan, V. Y. (2014) · Problems of Endocrinology · doi:10.14341/probl201460251-67 · Cited by 17
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
